Olympus Co. (OTCMKTS:OLYMY) Sees Significant Decrease in Short Interest

Olympus Co. (OTCMKTS:OLYMY) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totaling 17,276 shares, a decline of 60.1% from the July 15th total of 43,336 shares. Based on an average daily volume of 100,297 shares, the days-to-cover ratio is presently 0.2 days.

Analyst Ratings Changes

Separately, The Goldman Sachs Group lowered shares of Olympus from a “buy” rating to a “neutral” rating in a research report on Monday, June 15th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold”.

Olympus Trading Down 1.1%

Shares of OLYMY stock opened at $12.94 on Friday. Olympus has a twelve month low of $8.08 and a twelve month high of $13.73. The stock has a 50 day moving average of $11.02 and a 200 day moving average of $10.53.

Olympus Company Profile

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.